Ernexa Therapeutics Inc (ERNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2009 | 12-2008 | 12-2007 | 12-2006 | 12-2005 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 3,637 | 3,362 | 10,328 | 8,832 | 6,051 |
| Marketable Securities | 180 | 58 | 264 | 337 | 258 |
| Receivables | 606 | 636 | 1,354 | 1,874 | 2,153 |
| Other current assets | 0 | 0 | 212 | 3,040 | 7,679 |
| TOTAL | $5,057 | $4,667 | $12,903 | $14,991 | $17,070 |
| Non-Current Assets | |||||
| PPE Net | 3,809 | 3,428 | 4,101 | 5,919 | 7,810 |
| Intangibles | 2,787 | 1,217 | 1,603 | 2,535 | 3,001 |
| Other Non-Current Assets | 2,644 | 2,350 | 2,253 | 3,080 | 2,137 |
| TOTAL | $9,240 | $6,995 | $7,957 | $11,534 | $12,948 |
| Total Assets | $14,297 | $11,662 | $20,860 | $26,525 | $30,018 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | N/A | 700 |
| Accounts payable and accrued liabilities | 422 | 219 | 831 | 1,139 | 593 |
| Accrued Expenses | 1,863 | 1,840 | 1,705 | 2,158 | 2,365 |
| Other current liabilities | 294 | N/A | N/A | N/A | N/A |
| TOTAL | $4,257 | $3,700 | $5,205 | $7,729 | $8,439 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 523 | 657 | 972 | 1,826 | 2,052 |
| Other Non-Current Liabilities | 367 | 93 | 0 | 0 | 0 |
| TOTAL | $622 | $216 | $87 | $266 | $687 |
| Total Liabilities | $4,879 | $3,916 | $5,292 | $7,995 | $9,126 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 2 | 2 | 2 | 2 | 2 |
| Common Shares | 302 | 277 | 277 | 272 | 268 |
| Retained earnings | -106,868 | -105,351 | -98,870 | -93,561 | -88,788 |
| Other shareholders' equity | 244 | -447 | 1,219 | 202 | -448 |
| TOTAL | $9,418 | $7,746 | $15,568 | $18,530 | $20,892 |
| Total Liabilities And Equity | $14,297 | $11,662 | $20,860 | $26,525 | $30,018 |